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Abstract
Background: The prevalence of class III obesity (body mass index [BMI]$40 kg/m
2) has increased dramatically in several
countries and currently affects 6% of adults in the US, with uncertain impact on the risks of illness and death. Using data
from a large pooled study, we evaluated the risk of death, overall and due to a wide range of causes, and years of life
expectancy lost associated with class III obesity.
Methods and Findings: In a pooled analysis of 20 prospective studies from the United States, Sweden, and Australia, we
estimated sex- and age-adjusted total and cause-specific mortality rates (deaths per 100,000 persons per year) and
multivariable-adjusted hazard ratios for adults, aged 19–83 y at baseline, classified as obese class III (BMI 40.0–59.9 kg/m
2)
compared with those classified as normal weight (BMI 18.5–24.9 kg/m
2). Participants reporting ever smoking cigarettes or a
history of chronic disease (heart disease, cancer, stroke, or emphysema) on baseline questionnaires were excluded. Among
9,564 class III obesity participants, mortality rates were 856.0 in men and 663.0 in women during the study period (1976–
2009). Among 304,011 normal-weight participants, rates were 346.7 and 280.5 in men and women, respectively. Deaths
from heart disease contributed largely to the excess rates in the class III obesity group (rate differences=238.9 and 132.8 in
men and women, respectively), followed by deaths from cancer (rate differences=36.7 and 62.3 in men and women,
respectively) and diabetes (rate differences=51.2 and 29.2 in men and women, respectively). Within the class III obesity
range, multivariable-adjusted hazard ratios for total deaths and deaths due to heart disease, cancer, diabetes, nephritis/
nephrotic syndrome/nephrosis, chronic lower respiratory disease, and influenza/pneumonia increased with increasing BMI.
Compared with normal-weight BMI, a BMI of 40–44.9, 45–49.9, 50–54.9, and 55–59.9 kg/m
2 was associated with an
estimated 6.5 (95% CI: 5.7–7.3), 8.9 (95% CI: 7.4–10.4), 9.8 (95% CI: 7.4–12.2), and 13.7 (95% CI: 10.5–16.9) y of life lost. A
limitation was that BMI was mainly ascertained by self-report.
Conclusions: Class III obesity is associated with substantially elevated rates of total mortality, with most of the excess deaths
due to heart disease, cancer, and diabetes, and major reductions in life expectancy compared with normal weight.
Please see later in the article for the Editors’ Summary.
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Introduction
Obesity (body mass index [BMI]$30 kg/m
2) increases the risk
for numerous adverse health outcomes, including most major
chronic diseases [1–3]. Class III, or extreme, obesity (BMI$
40 kg/m
2) [4] is emerging as a major public health problem in
several developed countries [5–7], most notably in the US, where
BMI.30, 40, or 50 kg/m
2 among adults has increased more than
2-, 4-, and 10-fold, respectively, since the mid-1980s [8]. While
class III obesity currently affects 6% of the US adult population
[8,9], those belonging to this group accounted for 20% of the total
per capita health-care expenditures in 2000 [10].
Effective interventions and accurate projections of future health-
care costs requires a better understanding of the health risks
associated with class III obesity, but the necessary data are scarce.
Because class III obesity was relatively uncommon in the recent
past, the few studies that have specifically evaluated mortality rates
associated with class III obesity generally had limited sample sizes
(e.g., fewer than 400 deaths [2,11]) or did not separately evaluate
risks of death for BMI of 50 kg/m
2 or higher [2,3]. As such, there
is little quantitative information about the burden of disease,
including total and cause-specific mortality rates, for individuals
with BMI values of 40 kg/m
2 and above.
We combined original data from 20 prospective studies from the
United States, Sweden, and Australia to evaluate—in what is to
our knowledge the largest study on this topic to date—the excess
rates of death overall and due to a wide range of specific causes, as
well as the expected number of years of life lost attributable to class
III obesity.
Methods
Study Population
The study sample included participants from the 20 cohort
studies in the National Cancer Institute Cohort Consortium that
met the eligibility criteria (.5 y of follow-up, .1,000 deaths
among non-Hispanic white participants, baseline year 1970 or
later) and had the ability to submit data for a previous pooled
analysis of BMI and mortality [3], including the Adventist Health
Study–I [12], Agricultural Health Study [13], Breast Cancer
Detection Demonstration Project [14], California Teachers Study
[15], Cancer Prevention Study–II [16], CLUE–I and –II [17],
Cohort of Swedish Men [18], Health Professionals Follow-Up
Study [19], Iowa Women’s Health Study [20], Melbourne
Collaborative Cohort Study [21], New York University Women’s
Health Study [22], National Institutes of Health–American
Association of Retired Persons Diet and Health Study (NIH-
AARP) [23], Nurses’ Health Study–I [24], Physicians’ Health
Study–I and –II [25], Prostate, Lung, Colorectal and Ovarian
Cancer Screening Trial [26], Swedish Mammography Cohort
[27], Swedish Women’s Lifestyle and Health Study [28], United
States Radiologic Technologists Study [29], VITamins and
Lifestyle Study [30], and the Women’s Health Study [31].
Baseline was defined as the date of completion of the first
questionnaire that collected information on key variables (e.g.,
height, weight, smoking, and personal history of chronic diseases).
Personal history of chronic diseases and other important
covariates, including race/ethnicity, education, marital status,
alcohol consumption, and physical activity level, were self-
reported. Height and weight information was self-reported in all
but one cohort [21]. Individual-level data were formatted
uniformly across studies and combined.
Participants who were younger than 18 y or older than 85 y old
at baseline, participants with less than 1 y of follow-up, and
participants with BMI$60 kg/m
2 were excluded. We also
excluded participants who reported having ever smoked cigarettes
and/or a history of heart disease, cancer, stroke, or emphysema, as
tobacco use and these preexisting illnesses have been demonstrated
to confound the association between BMI and mortality [3]. The
final sample consisted of 9,564 individuals with a BMI of 40.0 to
59.9 kg/m
2 (1,575 men and 7,989 women) and 304,011 with a
BMI of 18.5 to 24.9 kg/m
2 (75,680 men and 228,331 women).
Follow-Up
Participants were followed from the date of completion of the
baseline questionnaire to death, loss to follow-up, or administrative
end date, whichever occurred first. Causes of death were
ascertained from death records or registries and coded according
to the Surveillance, Epidemiology, and End Results Program
recodes [32] based on cause of death codes defined by the
International Classification of Diseases, eighth, ninth, or tenth
revisions [33–35], and categorized according to the 2002 National
Vital Statistics Report of the US Centers for Disease Control and
Prevention [36].
Statistical Methods
We calculated age-adjusted mortality rates (number of deaths
per 100,000 persons per year) for the class III obesity (BMI 40.0–
59.9 kg/m
2) and normal-weight (BMI 18.5–24.9 kg/m
2) groups
using direct standardization for age [37], in which rates were
weighted according to the age distribution of the total US
population in 2000, restricted to ages 20–84 y, using 5-y categories
of attained age. We used the US standard to most closely
approximate the age distributions of the countries from which the
study populations were selected. Specific causes of death were
chosen from among the top leading causes of death in the US
population in 2000 [36], including (but not limited to) heart
disease, cerebrovascular disease, malignant neoplasms, chronic
lower respiratory diseases, accidents, diabetes mellitus, influenza
and pneumonia, kidney disease (nephritis, nephrotic syndrome,
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Mortality rates from suicide and homicide and from major causes
of death resulting in fewer than five events in both men and
women with BMI values of 40.0 kg/m
2 and above (e.g., Alzheimer
disease) are not shown. Within the major categories of heart
disease, malignant neoplasms, and cerebrovascular disease, where
the sample size was sufficient, we additionally calculated mortality
rates due to more specific causes (e.g., ischemic heart disease).
Rate differences were calculated as the difference in age-adjusted
mortality rates between the two BMI groups, and two-sided p-
values for these differences were calculated using a two-sample Z
test with the variance calculated under the assumption that the
number of deaths in each group followed an independent Poisson
distribution.
We used proportional hazards regression models, with attained
age as the underlying time metric, to calculate hazard ratios (HRs)
and 95% confidence intervals (CIs) for total mortality and
mortality due to major causes in relation to class III obesity
(BMI 40.0–59.9 kg/m
2) compared with normal weight (BMI
18.5–24.9 kg/m
2). All models were adjusted for sex, race/
ethnicity, education, alcohol intake, level of physical activity, and
study. In separate models, we additionally adjusted for self-
reported history of diabetes mellitus and hypertension to evaluate
the potential for mediation by these co-morbid conditions. In
separate models restricted to participants with BMI values
between 40.0 and 59.9 kg/m
2, BMI was included as a continuous
variable to evaluate HRs and 95% CIs per 5 kg/m
2 BMI and to
calculate tests for trend. We observed no evidence of violation of
the proportional hazards assumption based on graphical assess-
ment of cumulative hazards plots by BMI category.
To calculate years of life lost, we calculated direct adjusted
survivalcurvesforeachBMIcategory[38,39].Proportionalhazards
regression models were used to estimate probabilities of survival at
eachage for eachindividual, which werethen averaged to obtain an
overall summary curve. Curves for each BMI category were
estimated by counterfactual (i.e., applying the beta for each BMI
category in turn to estimate individual and overall survival curves).
Years of life lost were calculated as the difference between the
adjusted median life expectancy for a given BMI category and the
reference category of BMI 18.5–24.9 kg/m
2. Models were restrict-
ed to participants who were 40 y and older at baseline.
As a secondary analysis and alternative approach to combin-
ing results across studies, we additionally calculated pooled HRs
for class III obesity and total mortality using a random effects
meta-analysis model. Heterogeneity between studies was calcu-
lated using the I
2 index [40]. Confidence intervals for the I
2
index were calculated according to the method described by
Thorlund et al. [41]. We conducted subgroup analyses within
the aggregate dataset to evaluate potential sources of between-
study heterogeneity. For instance, because the association
between BMI and mortality has been shown to differ by age at
BMI measurement/report and sex [3], and medical care for
extremely obese individuals may have improved over calendar
time, we calculated HRs and 95% CIs within strata of these
factors. We also evaluated geographic location (US versus non-
US cohorts) as another potential source of between-study
heterogeneity. Tests for interaction by sex, geographic location
(US versus non-US cohorts), attained age, and calendar period of
follow-up (before and after age 65 y, and before and after the
year 2000) were conducted by including a cross-product term in
the model. Models evaluating interactions by attained age and
calendar period were time-dependent, in which person-time for
each participant was split before and after age 65 y or the year
2000.
Results
A description of participants with BMI in the class III obesity
range from each of the 20 cohorts is shown in Table 1. In total,
1,036 of the 9,564 participants died during the follow-up period
(median=9 y, maximum=27 y).
Compared with participants in the normal-weight range at
baseline, those in the class III obesity range included a higher
proportion of women, more individuals with baseline age 50 to
69 y (as opposed to younger [19–49 y] or older [70–83 y]
individuals), fewer non-Hispanic white individuals, fewer individ-
uals with a college education, more individuals with lower alcohol
intake, and more individuals with lower levels of physical activity
(Table 2). Among participants within the range of class III obesity,
we observed little variation in baseline age, sex, education, and
alcohol intake. By contrast, the prevalence of non-Hispanic black
race/ethnicity, low physical activity, and history of diabetes, as
well as median waist circumference, was generally higher for the
top BMI categories.
Table 3 compares total and cause-specific mortality rates
(deaths per 100,000 persons per year) for the class III obesity and
normal-weight groups separately by sex. Total mortality rates for
class III obesity participants were 856.0 in men and 663.0 in
women. The differences in mortality rates for the two BMI groups
were 509.3 and 382.5 in men and women, respectively. Heart
disease was the most common underlying cause of death for the
class III obesity group (mortality rate differences were 238.9 and
132.8 in men and women, respectively), followed by malignant
neoplasms (mortality rate differences were 36.7 and 62.3 in men
and women, respectively), and diabetes (mortality rate differences
were 51.2 and 29.2 in men and women, respectively). Higher rates
of death were also observed for nearly every other major cause of
death that we examined, apart from cerebrovascular disease in
men and malignant neoplasms of respiratory and intrathoracic
organs and diseases of the arteries, arterioles, and capillaries in
women, although not all of these differences were statistically
significant because of the relatively small numbers of deaths in the
class III obesity group for some of the major causes (e.g.,
malignant neoplasms, chronic lower respiratory disease, and
nephritis/nephrotic syndrome/nephrosis deaths in men). The
negative rate differences that were observed were also based on
small numbers of deaths in the class III obesity group (five, eight,
and five deaths due to cerebrovascular disease, malignant
neoplasms of respiratory and intrathoracic organs, and diseases
of the arteries, arterioles, and capillaries, respectively).
As an internal comparison, in the subset of participants in the
pooled dataset without heart disease, cancer, stroke, or emphyse-
ma and having BMI values between 18.5 and 24.9 kg/m
2,
differences in mortality rates for current versus never smokers were
721.0 and 519.6 in men and women, respectively.
Table 4 shows the minimally adjusted and multivariable-
adjusted HRs for death across categories of BMI and for
continuous (per 5 kg/m
2) values of BMI restricted to the BMI
40.0–59.9 kg/m
2 range. In minimally adjusted models, we
observed a sharp gradient in relative risk with higher values of
BMI across the class III obesity levels that was consistent with a
linear increase. The HRs from models of BMI categories were
slightly, but not fully, attenuated with additional adjustment for
race/ethnicity, education, alcohol intake, and physical activity
level. Compared with adults with BMI in the 18.5–24.9 kg/m
2
range, multivariable-adjusted HRs (95% CIs) for those with BMI
of 40.0–44.9, 45.0–49.9, 50.0–54.9, and 55.0–59.9 kg/m
2 were
2.25 (2.07–2.43), 3.32 (2.92–3.77), 3.48 (2.82–4.31), and 5.91
(4.24–8.24), respectively. This trend of increasing risk of death
Class III Obesity and Mortality: Pooled Analysis
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PLOS Medicine | www.plosmedicine.org 4 July 2014 | Volume 11 | Issue 7 | e1001673with increasing level of BMI was apparent in categorical and
continuous models (HR per 5 kg/m
2=1.40, 95% CI: 1.31–1.51)
after restricting to the BMI 40.0–59.9 kg/m
2 range.
Although the pooled HRs calculated from random effects meta-
analysis models were similar to those based on the aggregate
dataset (BMI 40.0–59.9 versus 18.5–24.9 kg/m
2, HR=2.57, 95%
CI: 2.23–2.96; per 5 kg/m
2 BMI, HR=1.42, 95% CI: 1.25–1.62),
the heterogeneity estimates for differences in the associations by
cohort were statistically significant (Figures 1 and 2). We evaluated
potential sources of heterogeneity in Table 5, which shows the
multivariable-adjusted HRs conducted overall and by population
subgroup. Overall, we observed a 2.57-fold (95% CI: 2.41–2.74)
increased risk of death in the BMI 40.0–59.9 kg/m
2 versus the
18.5–24.9 kg/m
2 group, and the association increased linearly for
BMI values above 40 kg/m
2 (HR per 5 kg/m
2=1.40, 95% CI:
1.31–1.51). As observed in studies of BMI across the entire range
of values in relation to mortality [3], these associations were
significantly modified by sex (p-interaction=0.03), by geographic
location (US versus non-US, p-interaction=0.03), and follow-up
time before and after age 65 y (p-interaction ,0.001), with
stronger associations observed for men (HR=2.83, 95% CI: 2.45–
3.26), for US cohorts (HR=2.60, 95% CI: 2.44–2.78), and for
follow-up before age 65 y (HR=3.10, 95% CI: 2.77–3.47). The
interaction by geographic location may have arisen due to chance,
Table 2. Baseline characteristics of participants in the pooled dataset by BMI category.
Characteristic BMI (kg/m
2)
18.5–24.9
(n=304,011)
40.0–44.9
(n=6,803)
45.0–49.9
(n=1,978)
50.0–54.9
(n=627)
55.0–59.9
(n=156)
Age
19–49 y 35% 23% 23% 21% 17%
50–59 y 27% 40% 40% 48% 44%
60–69 y 29% 33% 33% 27% 33%
7 0 – 8 3 y 9 %4 %4 %4 % 6 %
Sex
Male 25% 18% 14% 13% 19%
Female 75% 82% 86% 87% 81%
Race/ethnicity
White, non-Hispanic or unknown if Hispanic 93% 90% 88% 87% 85%
Black, non-Hispanic or unknown if Hispanic 1% 6% 8% 8% 10%
Hispanic 2% 2% 2% 2% 3%
Asian/Pacific Islander 3% ,1% ,1% ,1% 1%
Other/unknown 1% 2% 2% 1% 1%
Education
High school graduate or less 22% 31% 32% 26% 31%
Post–high school training/some college 21% 31% 31% 32% 38%
College graduate 54% 36% 33% 39% 28%
Unknown 3% 3% 4% 3% 3%
Alcohol intake
None 32% 45% 47% 48% 46%
.0t o,10 g of ethanol/day 44% 39% 36% 37% 37%
$10 g of ethanol/day 15% 5% 5% 5% 6%
Unknown 9% 10% 13% 11% 12%
Physical activity level (cohort-specific tertiles)
Low 21% 42% 44% 48% 53%
Medium 24% 20% 17% 15% 12%
High 32% 15% 14% 13% 14%
Unknown 23% 22% 26% 24% 22%
Waist circumference in cm (males), median
a 89 130 140 141 152
Waist circumference in cm (females), median
a 74 110 117 122 122
Prevalent conditions
a
Diabetes 2% 15% 17% 22% 22%
Hypertension 8% 27% 27% 24% 29%
Data are percent, unless otherwise indicated.
aAmong those without missing values. Proportion missing: waist circumference, 73%; diabetes, 8%; hypertension, 32%.
doi:10.1371/journal.pmed.1001673.t002
Class III Obesity and Mortality: Pooled Analysis
PLOS Medicine | www.plosmedicine.org 5 July 2014 | Volume 11 | Issue 7 | e1001673T
a
b
l
e
3
.
A
g
e
-
a
d
j
u
s
t
e
d
c
a
u
s
e
-
s
p
e
c
i
f
i
c
m
o
r
t
a
l
i
t
y
r
a
t
e
s
(
n
u
m
b
e
r
o
f
d
e
a
t
h
s
p
e
r
1
0
0
,
0
0
0
p
e
r
s
o
n
s
p
e
r
y
e
a
r
)
b
y
B
M
I
c
a
t
e
g
o
r
y
.
C
a
u
s
e
o
f
D
e
a
t
h
I
C
D
-
1
0
C
o
d
e
M
e
n
W
o
m
e
n
B
M
I
1
8
.
5
–
2
4
.
9
k
g
/
m
2
B
M
I
4
0
.
0
–
5
9
.
9
k
g
/
m
2
D
i
f
f
e
r
e
n
c
e
B
M
I
1
8
.
5
–
2
4
.
9
k
g
/
m
2
B
M
I
4
0
.
0
–
5
9
.
9
k
g
/
m
2
D
i
f
f
e
r
e
n
c
e
T
o
t
a
l
d
e
a
t
h
s
3
4
6
.
7
8
5
6
.
0
5
0
9
.
3
*
*
2
8
0
.
5
6
6
3
.
0
3
8
2
.
5
*
*
S
e
p
t
i
c
e
m
i
a
A
4
0
–
A
4
1
—
—
—
2
.
4
8
.
6
6
.
1
M
a
l
i
g
n
a
n
t
n
e
o
p
l
a
s
m
s
C
0
0
–
C
9
7
1
3
5
.
1
1
7
1
.
8
3
6
.
7
1
1
2
.
0
1
7
4
.
3
6
2
.
3
*
*
M
a
l
i
g
n
a
n
t
n
e
o
p
l
a
s
m
s
o
f
t
h
e
c
o
l
o
n
/
r
e
c
t
u
m
C
1
8
–
C
2
1
1
5
.
6
3
1
.
1
1
5
.
5
1
3
.
2
2
4
.
8
1
1
.
6
M
a
l
i
g
n
a
n
t
n
e
o
p
l
a
s
m
s
o
f
o
t
h
e
r
d
i
g
e
s
t
i
v
e
o
r
g
a
n
s
C
1
5
–
C
1
7
,
C
2
2
–
C
2
6
2
4
.
0
3
1
.
4
7
.
3
1
7
.
4
1
9
.
9
2
.
5
M
a
l
i
g
n
a
n
t
n
e
o
p
l
a
s
m
s
o
f
r
e
s
p
i
r
a
t
o
r
y
a
n
d
i
n
t
r
a
t
h
o
r
a
c
i
c
o
r
g
a
n
s
C
3
2
–
C
3
4
—
—
—
9
.
4
3
.
6
2
5
.
8
M
a
l
i
g
n
a
n
t
n
e
o
p
l
a
s
m
s
o
f
t
h
e
b
r
e
a
s
t
C
5
0
—
—
—
1
8
.
7
3
0
.
9
1
2
.
2
M
a
l
i
g
n
a
n
t
n
e
o
p
l
a
s
m
s
o
f
t
h
e
f
e
m
a
l
e
g
e
n
i
t
a
l
o
r
g
a
n
s
C
5
3
–
C
5
6
n
/
a
n
/
a
n
/
a
1
5
.
4
3
0
.
7
1
5
.
3
*
*
M
a
l
i
g
n
a
n
t
n
e
o
p
l
a
s
m
s
o
f
t
h
e
p
r
o
s
t
a
t
e
C
6
1
1
9
.
1
2
0
.
8
1
.
7
n
/
a
n
/
a
n
/
a
L
e
u
k
e
m
i
a
C
9
1
–
C
9
5
—
—
—
4
.
7
1
3
.
8
9
.
0
N
e
o
p
l
a
s
m
s
(
i
n
s
i
t
u
,
b
e
n
i
g
n
,
a
n
d
o
f
u
n
c
e
r
t
a
i
n
/
u
n
k
n
o
w
n
b
e
h
a
v
i
o
r
)
D
0
0
–
D
4
8
—
—
—
2
.
9
1
4
.
7
1
1
.
8
D
i
a
b
e
t
e
s
m
e
l
l
i
t
u
s
E
1
0
–
E
1
4
5
.
3
5
6
.
5
5
1
.
2
*
4
.
3
3
3
.
5
2
9
.
2
*
*
O
v
e
r
w
e
i
g
h
t
a
n
d
o
b
e
s
i
t
y
E
6
6
0
.
0
3
8
.
3
3
8
.
3
*
0
.
0
2
0
.
6
2
0
.
6
*
*
H
e
a
r
t
d
i
s
e
a
s
e
I
0
0
–
I
0
9
,
I
1
1
,
I
1
3
,
I
2
0
–
I
5
1
9
8
.
3
3
3
7
.
2
2
3
8
.
9
*
*
1
1
2
.
0
2
4
4
.
8
1
3
2
.
8
*
*
H
y
p
e
r
t
e
n
s
i
v
e
h
e
a
r
t
d
i
s
e
a
s
e
o
r
h
e
a
r
t
a
n
d
r
e
n
a
l
d
i
s
e
a
s
e
I
1
1
,
I
1
3
—
—
—
2
.
5
1
6
.
4
1
3
.
9
*
I
s
c
h
e
m
i
c
h
e
a
r
t
d
i
s
e
a
s
e
I
2
0
–
I
2
5
7
2
.
2
1
6
6
.
1
9
3
.
9
*
*
5
1
.
0
1
4
7
.
7
9
6
.
7
*
*
O
t
h
e
r
h
e
a
r
t
d
i
s
e
a
s
e
s
I
2
6
–
I
5
1
2
3
.
1
1
5
0
.
1
1
2
7
.
0
*
*
1
9
.
5
7
6
.
6
5
7
.
1
*
*
E
s
s
e
n
t
i
a
l
(
p
r
i
m
a
r
y
)
h
y
p
e
r
t
e
n
s
i
o
n
a
n
d
h
y
p
e
r
t
e
n
s
i
v
e
r
e
n
a
l
d
i
s
e
a
s
e
I
1
0
,
I
1
2
—
—
—
3
.
3
4
.
1
0
.
8
C
e
r
e
b
r
o
v
a
s
c
u
l
a
r
d
i
s
e
a
s
e
I
6
0
–
I
6
9
3
3
.
1
2
2
.
4
2
1
0
.
7
3
3
.
1
4
7
.
2
1
4
.
2
S
u
b
a
r
a
c
h
n
o
i
d
h
e
m
o
r
r
h
a
g
e
I
6
0
—
—
—
2
.
9
4
.
3
1
.
4
I
n
t
r
a
c
e
r
e
b
r
a
l
a
n
d
o
t
h
e
r
i
n
t
r
a
c
r
a
n
i
a
l
h
e
m
o
r
r
h
a
g
e
I
6
1
–
I
6
2
—
—
—
6
.
9
8
.
7
1
.
9
D
i
s
e
a
s
e
s
o
f
t
h
e
a
r
t
e
r
i
e
s
,
a
r
t
e
r
i
o
l
e
s
,
a
n
d
c
a
p
i
l
l
a
r
i
e
s
I
7
0
–
I
7
8
—
—
—
6
.
7
5
.
8
2
0
.
9
O
t
h
e
r
d
i
s
o
r
d
e
r
s
o
f
t
h
e
c
i
r
c
u
l
a
t
o
r
y
s
y
s
t
e
m
I
8
0
–
I
9
9
—
—
—
0
.
5
1
.
5
0
.
9
I
n
f
l
u
e
n
z
a
a
n
d
p
n
e
u
m
o
n
i
a
J
1
0
–
J
1
8
1
4
.
9
2
4
.
9
1
0
.
0
1
0
.
4
1
1
.
6
1
.
1
C
h
r
o
n
i
c
l
o
w
e
r
r
e
s
p
i
r
a
t
o
r
y
d
i
s
e
a
s
e
J
4
0
–
J
4
7
4
.
3
3
2
.
4
2
8
.
1
5
.
5
8
.
9
3
.
4
C
h
r
o
n
i
c
l
i
v
e
r
d
i
s
e
a
s
e
a
n
d
c
i
r
r
h
o
s
i
s
K
7
0
,
K
7
3
–
K
7
4
1
.
6
1
2
.
1
1
0
.
6
*
1
.
8
7
.
2
5
.
4
*
N
e
p
h
r
i
t
i
s
,
n
e
p
h
r
o
t
i
c
s
y
n
d
r
o
m
e
,
a
n
d
n
e
p
h
r
o
s
i
s
N
0
0
–
N
0
7
,
N
1
7
–
N
1
9
,
N
2
5
–
N
2
7
3
.
6
2
9
.
3
2
5
.
8
2
.
7
2
0
.
7
1
8
.
0
*
*
O
t
h
e
r
d
i
s
e
a
s
e
s
o
f
t
h
e
u
r
i
n
a
r
y
s
y
s
t
e
m
N
1
0
–
N
1
5
,
N
2
0
–
N
2
3
,
N
2
8
–
N
3
9
—
—
—
2
.
9
1
0
.
8
8
.
0
A
c
c
i
d
e
n
t
s
V
0
1
–
X
5
9
,
X
8
5
–
Y
8
6
—
—
—
1
3
.
7
2
2
.
9
9
.
2
M
o
r
t
a
l
i
t
y
r
a
t
e
s
w
e
r
e
a
g
e
-
s
t
a
n
d
a
r
d
i
z
e
d
u
s
i
n
g
t
h
e
a
g
e
d
i
s
t
r
i
b
u
t
i
o
n
o
f
a
d
u
l
t
s
a
g
e
d
2
0
–
8
4
y
i
n
t
h
e
2
0
0
0
U
S
c
e
n
s
u
s
p
o
p
u
l
a
t
i
o
n
;
n
o
t
s
h
o
w
n
i
f
c
a
l
c
u
l
a
t
i
o
n
s
b
a
s
e
d
o
n
f
e
w
e
r
t
h
a
n
f
i
v
e
d
e
a
t
h
s
i
n
t
h
e
B
M
I
4
0
.
0
–
5
9
.
9
k
g
/
m
2
g
r
o
u
p
.
*
p
,
0
.
0
5
;
*
*
p
,
0
.
0
0
1
.
I
C
D
-
1
0
,
I
n
t
e
r
n
a
t
i
o
n
a
l
C
l
a
s
s
i
f
i
c
a
t
i
o
n
o
f
D
i
s
e
a
s
e
s
,
t
e
n
t
h
r
e
v
i
s
i
o
n
;
n
/
a
,
n
o
t
a
p
p
l
i
c
a
b
l
e
.
d
o
i
:
1
0
.
1
3
7
1
/
j
o
u
r
n
a
l
.
p
m
e
d
.
1
0
0
1
6
7
3
.
t
0
0
3
Class III Obesity and Mortality: Pooled Analysis
PLOS Medicine | www.plosmedicine.org 6 July 2014 | Volume 11 | Issue 7 | e1001673as there were only 37 deaths in the class III obesity group among
non-US cohorts. No differences were observed for follow-up time
occurring before versus after the year 2000. The HR for
BMI 40.0–59.9 kg/m
2 versus 18.5–24.9 kg/m
2 did not change
importantly after excluding the largest cohort, NIH-AARP,
though the continuous HR for BMI values over 40 kg/m
2 was
slightly attenuated after this exclusion (HR=1.32, 95% CI: 1.20–
1.45). Exclusion of participants who reported a history of diabetes
at baseline slightly attenuated the HR for BMI 40.0–59.9 kg/m
2
versus 18.5–24.9 kg/m
2 (HR=2.27, 95% CI: 2.10–2.45). Exclu-
sion of the first 2 y of follow-up did not appreciably change the
HRs (,5% change). Although physical activity could confound or
mediate these associations, removal of the physical activity
variable also had little influence on the HRs (,5% change).
Multivariable-adjusted HRs for select major causes of death for
BMI 40.0–59.9 kg/m
2 compared with 18.5–24.9 kg/m
2 are
shown in Table 6. HRs were significantly elevated for deaths
due to heart disease, malignant neoplasms, cerebrovascular
disease, diabetes mellitus, nephritis/nephritic syndrome/nephro-
sis, chronic lower respiratory disease, influenza/pneumonia,
accidents, and septicemia, ranging from 1.69 for deaths due to
malignant neoplasms to 9.57 for deaths due to nephritis/nephrotic
syndrome/nephrosis. Additional adjustment for self-reported
history of diabetes and hypertension attenuated the HRs for all
specific causes of death apart from malignant neoplasms, though
all remained statistically significant. Within the BMI 40.0–
59.9 kg/m
2 range, greater BMI values were linearly associated
with increasing HRs for all of these major causes of death apart
from cerebrovascular disease, accidents, and septicemia; additional
adjustment for history of diabetes and hypertension had little
influence on these continuous HRs.
We estimated that BMI categories of 40–44.9, 45–49.9, 50–
54.9, and 55–59.9 kg/m
2 were associated with an estimated 6.5
(95% CI: 5.7–7.3), 8.9 (95% CI: 7.4–10.4), 9.8 (95% CI: 7.4–12.2),
and 13.7 (95% CI: 10.5–16.9) y of life lost (Table 7). These
estimates (95% CIs) were 6.5 (5.6–7.4), 10.8 (9.3–12.3), 10.6
(7.6–13.6), and 17.0 (12.9–21.1) in men and 6.9 (6.1–7.7), 9.1 (7.9–
10.3), 10.3 (8.3–12.3), and 13.1 (9.0–17.2) in women. By
comparison, in the subset of participants in the pooled dataset
without heart disease, cancer, stroke, or emphysema and having
BMI values between 18.5 and 24.9 kg/m
2, current versus never
cigarette smoking was associated with an estimated 8.9 y of life lost
(95% CI: 8.6–9.3).
Discussion
To our knowledge, this is the largest study to date on the
association between class III obesity and mortality, and the first to
show that class III obesity is associated with excess rates of total
mortality and mortality due to a wide range of causes, particularly
heart disease, cancer, and diabetes, and that the risk of death
overall and from these specific causes continues to rise with
increasing values of BMI. The accumulating excess risk resulted in
major reductions in life expectancy after the age of 40 y that were
comparable to those of cigarette smoking.
The estimated 6.5 to 13.7 y of life lost for BMI values between
40 and 59 kg/m
2 versus 18.5–24.9 kg/m
2 were in line with those
of a previous pooled analysis that found that individuals with BMI
values of 35–50 kg/m
2 had a median 8–10 fewer years of life than
those with BMI 22.5–24.9 kg/m
2 [2]. Our study further
demonstrates that the expected number of years of life lost
continued to increase for BMI values beyond 50 kg/m
2, at which
point the loss in life expectancy (9.8 y) exceeded that observed for
current versus never smoking (8.9 y) in this study. These results
have great relevance to the current era, during which class III
obesity rates have increased dramatically at the same time that
smoking rates have declined. That we observed a 7.2-y decrease in
life expectancy from BMI 40.0–44.9 to 55.0–59.9 kg/m
2 suggests
that otherwise healthy, non-smoking adults having BMI values
within the class III obesity range may considerably expand their
life expectancy by avoiding additional weight gain.
We observed significant differences in the relative risks for class
III obesity and total mortality by cohort, which may reflect
differencesin the ages, sexdistribution, and geographical location of
the participants, as these factors were shown to be significant effect
modifiers in our study. Similar to observations from previous studies
based on lower values of BMI [3], these results suggest that the risks
associated with class III obesity may be even greater for men than
women, and for younger compared to older adults. These results
could be considered in the development of public health interven-
tions aimed at reducing health risks associated with extreme obesity,
particularly those that are targeted toward susceptible populations.
Table 4. Hazard ratios and 95% confidence intervals for risk of death by BMI category.
Model Type BMI (kg/m
2) Category
Continuous BMI
(per 5 kg/m
2),
Restricted to BMI
40.0–59.9 kg/m
2
18.5–24.9
(n=304,011)
40.0–44.9
(n=6,803)
45.0–49.9
(n=1,978)
50.0–54.9
(n=627)
55.0–59.9
(n=156)
Number of deaths 17,047 669 245 87 35 1,036
Minimally adjusted models
a 1.00 (reference) 2.52 (2.33–2.72) 3.76 (3.32–4.27) 3.97 (3.21–4.90) 6.42 (4.61–8.95) 1.41 (1.31–1.52)
Multivariable-adjusted models
b 1.00 (reference) 2.25 (2.07–2.43) 3.32 (2.92–3.77) 3.48 (2.82–4.31) 5.91 (4.24–8.24) 1.40 (1.31–1.51)
Alternate reference group
models
b,c
— 1.00 (reference) 1.48 (1.28–1.72) 1.68 (1.34–2.10) 2.81 (1.99–3.97)
aModels use attained age as the underlying time metric and were adjusted for sex and study.
bModels use attained age as the underlying time metric, and are adjusted for sex, race/ethnicity (white [all participants in the Swedish and Australian cohorts were
coded as white], black, Asian/Pacific Islander, Hispanic, other/unknown), education (high school or less, post–high school, college, unknown), alcohol intake (grams of
ethanol per day: 0, .0t o,10, $10, unknown), physical activity level (cohort-specific tertiles corresponding to low, medium, and high), and study.
cUsing BMI=40.0–44.9 kg/m
2 as the reference group.
doi:10.1371/journal.pmed.1001673.t004
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death suggests that excess weight can have a wide range of
physiological effects. In particular, the results of our study suggest
that diabetes and hypertension are common mechanisms that might
explain the majority of the excess mortality burden in the class III
obesity group. Most of this excess was attributable to heart disease,
diabetes,cancer,andkidneyandliverdiseases,andrisksofdeathdue
to these causes were largely attenuated with additional adjustment
for diabetes and hypertension. Obesity is strongly associated with
metabolicabnormalities,includinginsulinresistance,type2diabetes,
hypertension, and dyslipidemia, mediated in part by the chronic
inflammatory state induced by the secretion of adipocytokines, such
asangiotensinogen,transforminggrowthfactor–beta,tumornecrosis
factor–alpha, and interleukin-six [42–45]. The severity of these
conditions has been shown to increase with increasing BMI [44] and
improve after weight loss either due to lifestyle modification or
bariatric surgery [46–49]. Diabetes, hypertension, and other obesity-
related aspects of the metabolic syndrome have been shown to play
an important role in the development of heart disease, chronic
kidney disease, and end-stage renal disease [42,45], among other
major causes of death observed to be elevated in the class III obesity
group. Thus, these metabolic conditions could be effect targets in
efforts to reducetheburden of morbidityandmortalityinindividuals
with extreme obesity. Individuals with extreme obesity may
experience other physiological impairments that could explain the
higher rates of death from other causes. Specifically, deaths due to
chronic lower respiratory disease were shown in this and the much
smallerNationalHealthand NutritionExaminationSurveyIIIstudy
to be elevated at extreme levels of BMI due to reduced lung capacity
and airway obstruction [50]. It is possible that excess risks associated
with class III obesity may decline as treatments for these co-morbid
conditions improve.
Figure 1. Cohort-specific and overall hazard ratios and 95% confidence intervals for BMI 40.0–59.9 kg/m
2 versus 18.5–24.9 kg/m
2.
Results for cohorts with fewer than five deaths in the BMI 40.0–59.9 kg/m
2 group are not shown. Cohort-specific models use attained age as the
underlying time metric, and are adjusted for sex, race/ethnicity (white [all participants in the Swedish and Australian cohorts were coded as white],
black, Asian/Pacific Islander, Hispanic, other/unknown), education (high school or less, post–high school, college, unknown), alcohol intake (grams of
ethanol per day: 0, .0t o,10, $10, unknown), and physical activity level (cohort-specific tertiles corresponding to low, medium, and high). Random
effects models were used to calculate overall (pooled) HRs and 95% CIs. The cohort acronyms are identified in Table 1, and references are given in
parentheses.
doi:10.1371/journal.pmed.1001673.g001
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sufficient numbers, we were able to quantify the risks of total and
cause-specific deaths associated with class III obesity with greater
precision than has been possible in previous studies. Furthermore,
our results were based on a population of never smokers without
prevalent disease, thereby reducing the potential for confounding
due to major preexisting illness and smoking. Our results were also
based on original, as opposed to published, data, which allowed for
standardization of the variables and statistical methods across
studies, and thereby reduced the potential for methodological
heterogeneity between studies.
Some limitations of this study include the use of mostly self-
reported, as opposed to measured, height and weight. Objectively
measured values are ideal, but epidemiologic studies have reported
high correlations between self-reported and measured height
and weight [51,52]. Nonetheless, misclassification across BMI
categories due to self-reported height and weight has been shown
to yield stronger relative risks than those based on measured values
[53]. This potential source of bias may have inflated our relative
risk estimates, although this effect is likely to have been modest [3].
Another limitation is that height and weight were ascertained only
once at the beginning of follow-up, which precluded us from
examining risks associated with weight change. Although BMI is
the most commonly used indicator of adiposity in epidemiologic
studies, it does not directly measure the amount of adipose tissue
and cannot distinguish between fat and lean body mass [54,55].
Nonetheless, BMI has been shown to be just as strongly correlated
with obesity-related metabolic indicators as more accurate
methods for measuring total fat mass and body fat percent, such
as dual-energy X-ray absorptiometry [55]. BMI also does not
provide information on central versus peripheral body fat
distribution, each posing different risks in relation to the metabolic
Figure 2. Cohort-specific and overall hazard ratios and 95% confidence intervals for continuous BMI (per 5 kg/m
2). Analyses were
restricted to participants with BMI 40.0–59.9 kg/m
2. Results for cohorts with fewer than five deaths in the BMI 40.0–59.9 kg/m
2 group are not shown.
Cohort-specific models use attained age as the underlying time metric, and are adjusted for sex, race/ethnicity (white [all participants in the Swedish
and Australian cohorts were coded as white], black, Asian/Pacific Islander, Hispanic, other/unknown), education (high school or less, post–high
school, college, unknown), alcohol intake (grams of ethanol per day: 0, .0t o,10, $10, unknown), and physical activity level (cohort-specific tertiles
corresponding to low, medium, and high). Random effects models were used to calculate overall (pooled) HRs and 95% CIs. The cohort acronyms are
identified in Table 1, and references are given in parentheses.
doi:10.1371/journal.pmed.1001673.g002
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BMI with measures of central adiposity may yield more accurate
estimates of disease risks associated with high levels BMI [57,58].
For instance, in a pooled analysis based on data from the same 20
cohort studies, waist circumference was positively associated with
all-cause mortality, even among individuals at the highest range of
BMI (35.0–49.9 kg/m
2) [58]. There has been some concern about
the accuracy of cause of death reports [59], which may be
differential by BMI level. The excess deaths due to both diabetes
mellitus and overweight and obesity that we observed in the class
III obesity group may reflect greater difficulty in identifying the
primary cause of death among individuals with multiple co-
morbid conditions. Our results may not be generalizable to all
populations, as the pooled dataset comprised mostly non-Hispanic
white individuals from affluent countries (the majority being from
the US). Also, our estimates rely on prospective cohort studies,
whose volunteer participants typically are healthier than those in
the general population.
In this large pooled analysis of 20 prospective studies,
participants with BMI in the class III obesity range (40.0–
59.9 kg/m
2) experienced substantially higher rates of death
compared with those in the normal BMI range (18.5–24.9 kg/m
2),
Table 5. Hazard ratios and 95% confidence intervals for risk of death according to BMI category (40.0–59.9 versus 18.5–24.9 kg/
m
2) or continuous values of BMI between 40.0 and 59.9 kg/m
2 (per 5 kg/m
2): subgroup analyses.
Subgroup Category Categorical BMI Continuous BMI
BMI 18.5–24.9 kg/m
2
(n=304,011)
BMI 40.0–59.9 kg/m
2
(n=9,564) p-Interaction*
Per 5 kg/m
2 for BMI
40.0–59.9 kg/m
2
(n=9,564) p-Interaction*
Overall Number of deaths 17,047 1,036 1,036
HR (95% CI)
a 1.00 (reference) 2.57 (2.41–2.74) 1.40 (1.31–1.51)
By sex Men
Number of deaths 5,404 212 212
HR (95% CI)
a 1.00 (reference) 2.83 (2.45–3.26) 1.54 (1.32–1.81)
Women
Number of deaths 11,643 824 824
HR (95% CI)
a 1.00 (reference) 2.53 (2.35–2.73) 0.03 1.37 (1.26–1.49) 0.01
By attained age Follow-up before age 65 y
Number of deaths 3,830 368 368
HR (95% CI)
a,b 1.00 (reference) 3.10 (2.77–3.47) 1.59 (1.42–1.79)
Follow-up after age 65 y
Number of deaths 13,217 668 668
HR (95% CI)
a,c 1.00 (reference) 2.34 (2.16–2.53) ,0.001 1.30 (1.18–1.43) ,0.001
By calendar year Follow-up before 2000
Number of deaths
HR (95% CI)
a,d 1.00 (reference) 2.50 (2.28–2.76) 1.35 (1.21–1.51)
Follow-up after 2000
Number of deaths
HR (95% CI)
a,e 1.00 (reference) 2.48 (2.27–2.71) 0.50 1.45 (1.32–1.60) 0.34
By geography US cohorts only
Number of deaths 15,770 999 999
HR (95% CI)
a 1.00 (reference) 2.60 (2.44–2.78) 1.39 (1.29–1.50)
Non-US cohorts only
Number of deaths 1,277 37 37
HR (95% CI)
a 1.00 (reference) 1.88 (1.34–2.63) 0.03 1.71 (1.17–2.50) 0.04
*Calculated by including a cross-product term between the subgroup variable and BMI (40.0–59.9 versus 18.5–24.9 kg/m
2); subgroup analyses for attained age and
calendar year were stratified by follow-up period.
aModels use attained age as the underlying time metric, and are adjusted for sex, race/ethnicity (white [all participants in the Swedish and Australian cohorts were
coded as white], black, Asian/Pacific Islander, Hispanic, other/unknown), education (high school or less, post–high school, college, unknown), alcohol intake (grams of
ethanol per day: 0, .0t o,10, $10, unknown), physical activity level (cohort-specific tertiles corresponding to low, medium, and high), and study.
bModels excluded participants who entered the study at or after age 65 y; follow-up time was censored at age at study exit (due to loss to follow-up, death,o r
administrative end date) or age 65 y, whichever came first.
cModels excluded participants who exited the study at or before age 65 y; follow-up began at age 65 y for those who entered the study before age 65 y.
dModels excluded participants who entered the study on or after the year 2000; follow-up time was censored at study exit (due to loss to follow-up, death,o r
administrative end date) or the year 2000, whichever came first.
eModels excluded participants who exited the study on or before the year 2000; follow-up began in the year 2000 for those who entered the study before the year 2000.
doi:10.1371/journal.pmed.1001673.t005
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PLOS Medicine | www.plosmedicine.org 10 July 2014 | Volume 11 | Issue 7 | e1001673with most of the excess due to deaths from heart disease, cancer,
and diabetes. These higher rates appear to be largely attributable
to metabolic abnormalities associated with excess adiposity,
including diabetes and hypertension. We found that the reduction
in life expectancy associated with class III obesity was similar to
(and, for BMI values above 50 kg/m
2, even greater than) that
Table 6. Hazard ratios and 95% confidence intervals for select major causes of death by BMI category.
Model Type Categorical BMI
Continuous BMI (per 5 kg/m
2)f o r
BMI 40.0–59.9 kg/m
2 (n=9,564)
18.5–24.9 kg/m
2
(n=304,011)
40.0–59.9 kg/m
2
(n=9,564)
Total deaths
Number of deaths 17,047 1,036 1,036
HR (95% CI) for multivariable model
a 1.00 (reference) 2.57 (2.41–2.74) 1.40 (1.31–1.51)
HR (95% CI) for additionally adjusted model
b 1.00 (reference) 2.10 (1.96–2.25) 1.39 (1.29–1.49)
Heart disease
Number of deaths 3,813 345 345
HR (95% CI) for multivariable model
a 1.00 (reference) 4.03 (3.83–4.84) 1.30 (1.14–1.48)
HR (95% CI) for additionally adjusted model
b 1.00 (reference) 3.26 (2.89–3.68) 1.28 (1.13–1.46)
Malignant neoplasms
Number of deaths 7,161 294 294
HR (95% CI) for multivariable model
a 1.00 (reference) 1.69 (1.50–1.90) 1.27 (1.10–1.47)
HR (95% CI) for additionally adjusted model
b 1.00 (reference) 1.63 (1.45–1.84) 1.28 (1.10–1.47)
Cerebrovascular disease
Number of deaths 1,599 52 52
HR (95% CI) for multivariable model
a 1.00 (reference) 1.67 (1.26–2.22) 0.73 (0.46–1.16)
HR (95% CI) for additionally adjusted model
b 1.00 (reference) 1.35 (1.01–1.80) 0.69 (0.43–1.10)
Diabetes mellitus
Number of deaths 235 61 61
HR (95% CI) for multivariable model
a 1.00 (reference) 8.82 (6.46–12.05) 1.55 (1.16–2.06)
HR (95% CI) for additionally adjusted model
b 1.00 (reference) 2.24 (1.61–3.11) 1.50 (1.13–1.99)
Nephritis, nephrotic syndrome, and nephrosis
Number of deaths 149 36 36
HR (95% CI) for multivariable model
a 1.00 (reference) 9.57 (6.41–14.27) 2.14 (1.55–2.97)
HR (95% CI) for additionally adjusted model
b 1.00 (reference) 6.27 (4.11–9.57) 2.06 (1.48–2.85)
Chronic lower respiratory disease
Number of deaths 255 17 17
HR (95% CI) for multivariable model
a 1.00 (reference) 2.33 (1.39–3.88) 2.00 (1.21–3.31)
HR (95% CI) for additionally adjusted model
b 1.00 (reference) 2.15 (1.28–3.62) 2.02 (1.21–3.36)
Influenza and pneumonia
Number of deaths 508 18 18
HR (95% CI) for multivariable model
a 1.00 (reference) 1.82 (1.13–2.95) 1.76 (1.09–2.85)
HR (95% CI) for additionally adjusted model
b 1.00 (reference) 1.45 (0.89–2.37) 1.75 (1.07–2.86)
Accidents (unintentional injuries)
Number of deaths 771 31 31
HR (95% CI) for multivariable model
a 1.00 (reference) 1.76 (1.22–2.53) 1.16 (0.74–1.82)
HR (95% CI) for additionally adjusted model
b 1.00 (reference) 1.61 (1.10–2.34) 1.15 (0.73–1.79)
Septicemia
Number of deaths 139 14 14
HR (95% CI) for multivariable model
a 1.00 (reference) 3.95 (2.21–7.08) 1.32 (0.68–2.55)
HR (95% CI) for additionally adjusted model
b 1.00 (reference) 3.10 (1.69–5.67) 1.30 (0.67–2.51)
aModels use attained age as the underlying time metric, and are adjusted for sex, race/ethnicity (white [all participants in the Swedish and Australian cohorts were
coded as white], black, Asian/Pacific Islander, Hispanic, other/unknown), education (high school or less, post–high school, college, unknown), alcohol intake (grams of
ethanol per day: 0, .0t o,10, $10, unknown), physical activity level (cohort-specific tertiles corresponding to low, medium, and high), and study.
bAdditionally adjusted for history of diabetes (ever diagnosed, never diagnosed, or unknown) and hypertension (ever diagnosed, never diagnosed, or unknown).
doi:10.1371/journal.pmed.1001673.t006
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PLOS Medicine | www.plosmedicine.org 11 July 2014 | Volume 11 | Issue 7 | e1001673observed for current smoking. If current global trends in obesity
continue, we must expect to see substantially increased rates of
mortality due to these major causes of death, as well as rising
health-care costs. These results underscore the need to develop
more effective interventions to combat this growing public health
problem.
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Background. The number of obese people (individuals with
an excessive amount of body fat) is increasing rapidly in
many countries. Worldwide, according to the Global Burden
of Disease Study 2013, more than a third of all adults are now
overweight or obese. Obesity is defined as having a body
mass index (BMI, an indicator of body fat calculated by
dividing a person’s weight in kilograms by their height in
meters squared) of more than 30 kg/m
2 (a 183-cm [6-ft] tall
man who weighs more than 100 kg [221 lbs] is obese).
Compared to people with a healthy weight (a BMI between
18.5 and 24.9 kg/m
2), overweight and obese individuals
(who have a BMI between 25.0 and 29.9 kg/m
2 and a BMI of
30 kg/m
2 or more, respectively) have an increased risk of
developing diabetes, heart disease, stroke, and some
cancers, and tend to die younger. Because people become
unhealthily fat by consuming food and drink that contains
more energy (kilocalories) than they need for their daily
activities, obesity can be prevented or treated by eating less
food and by increasing physical activity.
Why Was This Study Done? Class III obesity (extreme, or
morbid, obesity), which is defined as a BMI of more than
40 kg/m
2, is emerging as a major public health problem in
several high-income countries. In the US, for example, 6% of
adults are now morbidly obese. Because extreme obesity
used to be relatively uncommon, little is known about the
burden of disease, including total and cause-specific mor-
tality (death) rates, among individuals with class III obesity.
Before we can prevent and treat class III obesity effectively,
we need a better understanding of the health risks
associated with this condition. In this pooled analysis of
prospective cohort studies, the researchers evaluate the risk
of total and cause-specific death and the years of life lost
associated with class III obesity. A pooled analysis analyzes
the data from several studies as if the data came from one
large study; prospective cohort studies record the charac-
teristics of a group of participants at baseline and follow
them to see which individuals develop a specific condition.
What Did the Researchers Do and Find? The researchers
included 20 prospective (mainly US) cohort studies from the
National Cancer Institute Cohort Consortium (a partnership
that studies cancer by undertaking large-scale collabora-
tions) in their pooled analysis. After excluding individuals
who had ever smoked and people with a history of chronic
disease, the analysis included 9,564 adults who were
classified as class III obese based on self-reported height
and weight at baseline and 304,011 normal-weight adults.
Among the participants with class III obesity, mortality rates
(deaths per 100,000 persons per year) during the 30-year
study period were 856.0 and 663.0 in men and women,
respectively, whereas the mortality rates among normal-
weight men and women were 346.7 and 280.5, respectively.
Heart disease was the major contributor to the excess death
rate among individuals with class III obesity, followed by
cancer and diabetes. Statistical analyses of the pooled data
indicate that the risk of all-cause death and death due to
heart disease, cancer, diabetes, and several other diseases
increased with increasing BMI. Finally, compared with having
a normal weight, having a BMI between 40 and 59 kg/m
2
resulted in an estimated loss of 6.5 to 13.7 years of life.
What Do These Findings Mean? These findings indicate
that class III obesity is associated with a substantially
increased rate of death. Notably, this death rate increase is
similar to the increase associated with smoking among
normal-weight people. The findings also suggest that heart
disease, cancer, and diabetes are responsible for most of the
excess deaths among people with class III obesity and that
having class III obesity results in major reductions in life
expectancy. Importantly, the number of years of life lost
continues to increase for BMI values above 50 kg/m
2, and
beyond this point, the loss of life expectancy exceeds that
associated with smoking among normal-weight people. The
accuracy of these findings is limited by the use of self-
reported height and weight measurements to calculate BMI
and by the use of BMI as the sole measure of obesity.
Moreover, these findings may not be generalizable to all
populations. Nevertheless, these findings highlight the need
to develop more effective interventions to combat the
growing public health problem of class III obesity.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001673.
N The US Centers for Disease Control and Prevention
provides information on all aspects of overweight and
obesity (in English and Spanish)
N The World Health Organization provides information on
obesity (in several languages); Malri’s story describes the
health risks faced by an obese child
N The UK National Health Service Choices website provides
information about obesity, including a personal story
about losing weight
N The Global Burden of Disease Study website provides the
latest details about global obesity trends
N The US Department of Agriculture’s ChooseMyPlate.gov
website provides a personal healthy eating plan; the
Weight-Control Information Network is an information
service provided for the general public and health
professionals by the US National Institute of Diabetes
and Digestive and Kidney Diseases (in English and Spanish)
N MedlinePlus provides links to other sources of information
on obesity (in English and Spanish)
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